Adenoid cystic carcinoma (AdCC) is one of the most common salivary gland malignancies and occurs in all major and minor salivary gland and seromucous gland sites. AdCCs of salivary gland origin have long been categorized as fusion-defined carcinomas owing to the almost consistent presence of fusion genes MYB::NFIB, or less commonly MYBL1::NFIB. We collected a cohort of 95 cases of AdCC, which were largely characterized by canonical fusions MYB::NFIB (49 cases) or MYBL1::NFIB (9 cases). In additional 11 cases of AdCC, rearrangements in MYB or NFIB genes were detected by FISH. In addition, NGS revealed novel noncanonical fusion transcripts EWSR1::MYB; ACTB::MYB; ESRRG::DNM3, MYB::TULP4, and ACTN4::MYB, each of them in 1 case. The tumors that showed noncanonical fusions had features of metatypical AdCC with a diverse architecture, lobulated multinodular growth pattern, and hypercellular peripheral palisading of nuclei (2 cases), tubular hypereosinophilia (2 cases), and pale eosinophilic to vacuolated (bubbly) cytoplasm (3 cases). Our study documented 3 cases of AdCC of salivary glands harboring novel gene fusions TULP4::MYB, ACTN4::MYB, and ACTB::MYB, in 1 case each, which have not been described before. A rare EWSR1::MYB fusion was detected in 1 case. Moreover, 1 case of sinonasal metatypical AdCC showed EWSR1 rearrangement detected by FISH. Also, 1 case with an ESRRG::DNM3 fusion of unknown significance is described in this study. These discoveries illustrate how broad molecular profiling will expand understanding of changes in known entities.

Bioptic Laboratory Ltd Pilsen Czech Republic

Department of Pathology and Molecular Pathology University Hospital Zurich Zurich Switzerland

Department of Pathology Faculty of Medicine in Pilsen Charles University Czech Republic

Department of Pathology National Oncologic Institute Bratislava Slovak Republic

Institute of Biomedicine Pathology University of Turku and Department of Pathology Turku University Hospital Turku Finland

Institute of Pathology University Hospital Erlangen Friedrich Alexander University Erlangen Nürnberg Erlangen Germany

Molecular and Genetic Laboratory Bioptic Laboratory Ltd Pilsen Czech Republic

The University of Kansas School of Medicine Kansas City KS

Zobrazit více v PubMed

WHO Classification of Tumors Editorial Board. Head and Neck Tumors. International Agency for Research on Cancer; 2023(WHO Classification of Tumors Series, 5th ed.; vol. 9).https://publications.iarc.who.int/629.

Skálová A, Hyrcza MD, Vaneček T, et al. . Fusion-positive salivary gland carcinomas. Genes Chromosomes Cancer. 2022;61:228–243. PubMed

Skalova A, Vanecek T, Sima R, et al. . Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608. PubMed

Skalova A, Vanecek T, Martinek P, et al. . Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol. 2018;42:234–246. PubMed

Rooper L, Karantanos T, Ning Y, et al. . Salivary secretory carcinoma with a novel ETV6-MET fusion. Am J Surg Pathol. 2018;42:1121–1126. PubMed

Skálová A, Banečkova M, Thompson LDR, et al. . Expanding the molecular spectrum of secretory carcinoma of salivary glands with a novel VIM-RET fusion. Am J Surg Pathol. 2020;44:1295–1307. PubMed

Mitani Y, Li J, Rao PH, et al. . Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010;16:4722–4731. PubMed PMC

Mitani Y, Liu B, Rao PH, et al. . Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations. Clin Cancer Res. 2016;22:725–733. PubMed PMC

Weinreb I, Rooper LM, Dickson BC, et al. . Adenoid cystic carcinoma with striking tubular hypereosinophilia: a unique pattern associated with nonparotid location and both canonical and novel EWSR1::MYB and FUS::MYB fusions. Am J Surg Pathol. 2023;47:497–503. PubMed

Mitani Y, Rao PH, Futreal PA, et al. . Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011;17:7003–7014. PubMed PMC

Landrum MJ, Lee JM, Benson M, et al. . ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D1067. PubMed PMC

Koboldt DC. Best practices for variant calling in clinical sequencing. Genome Med. 2020;12:91. PubMed PMC

Šteiner P, Andreasen S, Grossmann P, et al. . Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands. Virchows Arch. 2018;473:471–480. PubMed

Michal M, Berry RS, Rubin BP, et al. . EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex group of fibroblastic/myofibroblastic neoplasms. Am J Surg Pathol. 2018;42:1325–1333. PubMed

Altemani A, Costa AF, Montalli VA, et al. . Signet-ring cell change in adenoid cystic carcinoma: a clinicopathological and immunohistochemical study of four cases. Histopathology. 2013;62:531–542. PubMed

Persson M, Andrén Y, Mark J, et al. . Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106:18740–18744. PubMed PMC

Rooper LM, Lombardo KA, Oliai BR, et al. . MYB RNA in situ hybridization facilitates sensitive and specific diagnosis of adenoid cystic carcinoma regardless of translocation status. Am J Surg Pathol. 2021;45:488–497. PubMed

Ho AS, Ochoa A, Jayakumaran G, et al. . Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma. J Clin Invest. 2019;129:4276–4289. PubMed PMC

Wagner VP, Bingle CD, Bingle L. MYB-NFIB fusion transcript in adenoid cystic carcinoma: current state of knowledge and future directions. Crit Rev Oncol Hematol. 2022;176:103745. PubMed

Frerich CA, Sedam HN, Kang H, et al. . N-terminal truncated Myb with new transcriptional activity produced through use of an alternative MYB promoter in salivary gland adenoid cystic carcinoma. Cancers (Basel). 2019;12:45. PubMed PMC

Drier Y, Cotton MJ, Williamson KE, et al. . An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. 2016;48:265–272. PubMed PMC

Gao R, Cao C, Zhang M, et al. . A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets. Oncotarget. 2014;5:12528–12542. PubMed PMC

Corradini F, Cesi V, Bartella V, et al. . Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants. J Biol Chem. 2005;280:30254–30262. PubMed

Mathew EP, Todorovic E, Truong T, et al. . Metatypical adenoid cystic carcinoma: a variant showing prominent squamous differentiation with a predilection for the sinonasal tract and skull base. Am J Surg Pathol. 2022;46:816–822. PubMed

Mukhopadhyay S, Jackson PK. The tubby family proteins. Genome Biol. 2011;12:225. PubMed PMC

Raghav Y, Dilliott AA, Petrozziello T, et al. . Identification of gene fusions associated with amyotrophic lateral sclerosis. Muscle Nerve. 2024;69:477–489. PubMed

Liu H, Murphy CJ, Karreth FA, et al. . Identifying and targeting sporadic oncogenic genetic aberrations in mouse models of triple-negative breast cancer. Cancer Discov. 2018;8:354–369.Erratum in: Cancer Discov. 2018 Aug;8(8):1044. PubMed PMC

Molecular Profiling of Sinonasal Adenoid Cystic Carcinoma: Canonical and Noncanonical Gene Fusions and Mutation